Related references
Note: Only part of the references are listed.Epidemiological and etiological variations in hepatocellular carcinoma
Evangelista Sagnelli et al.
INFECTION (2020)
Long noncoding RNA FER1L4 acts as an oncogenic driver in human pan-cancer
Zilong You et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma
A. Cox et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2020)
Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
Naomi Lange et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Disease Burden of Hepatocellular Carcinoma: A Global Perspective
Mehmet Sayiner et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
FER1L4/miR-372/E2F1 works as a ceRNA system to regulate the proliferation and cell cycle of glioma cells
Liang Xia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2FI, E2F3, and Caspase-3
Rui Han et al.
CANCER MANAGEMENT AND RESEARCH (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Ferlin Overview: From Membrane to Cancer Biology
Olivier Peulen et al.
CELLS (2019)
Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway
Xu Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
CDCA5, Transcribed by E2F1, Promotes Oncogenesis by Enhancing Cell Proliferation and Inhibiting Apoptosis via the AKT Pathway in Hepatocellular Carcinoma
Hao Chen et al.
JOURNAL OF CANCER (2019)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang et al.
ABDOMINAL RADIOLOGY (2018)
microRNA-372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1
Ya-Xin Zhao et al.
MOLECULAR MEDICINE REPORTS (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Long non-coding RNA Fer-1-like protein 4 acts as a tumor suppressor via miR-106a-5p and predicts good prognosis in hepatocellular carcinoma
Ju Wu et al.
CANCER BIOMARKERS (2017)
Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer
Ben Yue et al.
CANCER SCIENCE (2015)
Downregulation of miR-363 increases drug resistance in cisplatin-treated HepG2 by dysregulating Mcl-1
Yangyang Ou et al.
GENE (2015)
Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1
Jun Qin et al.
GENE (2014)
Clinical significance of the low expression of FER1L4 in gastric cancer patients
Zhong Liu et al.
TUMOR BIOLOGY (2014)
miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK
Feng Zhi et al.
PLOS ONE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
The diverse and complex roles of NF-κB subunits in cancer
Neil D. Perkins
NATURE REVIEWS CANCER (2012)
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status
Guang Yang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Chronic Hepatitis C Infection
Hugo R. Rosen
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Deregulated expression of miR-106a predicts survival in human colon cancer patients
Raquel Diaz et al.
GENES CHROMOSOMES & CANCER (2008)
Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-κB upon TLR4 activation
Ching-Aeng Lim et al.
MOLECULAR CELL (2007)
NF-kB in development and progression of human cancer
X Dolcet et al.
VIRCHOWS ARCHIV (2005)
E2F1 and c-Myc potentiate apoptosis through inhibition of NF-κB activity that facilitates MnSOD-mediated ROS elimination
H Tanaka et al.
MOLECULAR CELL (2002)